NO135338B - - Google Patents

Download PDF

Info

Publication number
NO135338B
NO135338B NO4050/72A NO405072A NO135338B NO 135338 B NO135338 B NO 135338B NO 4050/72 A NO4050/72 A NO 4050/72A NO 405072 A NO405072 A NO 405072A NO 135338 B NO135338 B NO 135338B
Authority
NO
Norway
Prior art keywords
general formula
succinimide
compound
piperidyl
substituted
Prior art date
Application number
NO4050/72A
Other languages
Norwegian (no)
Other versions
NO135338C (en
Inventor
M F Berry
S H Reesman
M L Smith
P Q Van Middlesworth
Original Assignee
Gen Foods Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Foods Corp filed Critical Gen Foods Corp
Publication of NO135338B publication Critical patent/NO135338B/no
Publication of NO135338C publication Critical patent/NO135338C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/22Working-up of proteins for foodstuffs by texturising
    • A23J3/225Texturised simulated foods with high protein content
    • A23J3/227Meat-like textured foods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/22Working-up of proteins for foodstuffs by texturising
    • A23J3/26Working-up of proteins for foodstuffs by texturising using extrusion or expansion
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/25Shaping or working-up of animal feeding-stuffs by extrusion
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/30Puffing or expanding
    • A23P30/32Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
    • A23P30/34Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment by extrusion-expansion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Hydrogenated Pyridines (AREA)

Description

Fremgangsmåte for fremstilling av substituerte succinimider. Process for the preparation of substituted succinimides.

Foreliggende oppfinnelse angår en fremgangsmåte for frmstilling av nye substituerte succinimider med den alminnelige formel I: The present invention relates to a process for the production of new substituted succinimides with the general formula I:

hvor R, og R., kan være like eller forskjel-lige og hver bety et hydrogenatom eller en lavere alkylgruppe. where R, and R., can be the same or different and each means a hydrogen atom or a lower alkyl group.

I henhold til oppfinnelsen blir forbin-delsene med formel I fremstillet ved at et substituert piperidon-4 med den alminnelige formel II: According to the invention, the compounds of formula I are prepared by a substituted piperidone-4 with the general formula II:

hvor R,' står for en lavere alkyl- eller en benzylgruppe, omsettes med en forbindelse med den alminnelige formel III: hvor X står for cyangruppen eller en eventuelt funksjonelt omdannet karboksyl - gruppe, i nærvær av en vannavspaltende katalysator til et piperidyliden-4-derivat med den alminnelige formel IV: hvoretter denne ved tilleiring av blåsyre overføres til en forbindelse med den alminnelige formel V: og denne ved hydrolyse, dekarboksyiering og forestring med en alkohol overføres til en substituert ravsyre-diester med den alminnelige formel VI: where R,' stands for a lower alkyl or a benzyl group, is reacted with a compound of the general formula III: where X stands for the cyano group or an optionally functionally converted carboxyl group, in the presence of a water-splitting catalyst to a piperidylidene-4- derivative with the general formula IV: after which this, by addition of hydrocyanic acid, is transferred to a compound with the general formula V: and this, by hydrolysis, decarboxylation and esterification with an alcohol, is transferred to a substituted succinic acid diester with the general formula VI:

hvoretter den dannede ester omsettes med en nitrogenforbindelse med den alminnelige formel R2 - NH„ hvor R2 har samme betydning som ovenfor og, hvis R,' står for en benzylgruppe, avspaltes denne re-duktivt og den dannede sekundære amino-gruppe eventuelt alkyleres. after which the formed ester is reacted with a nitrogen compound with the general formula R2 - NH„ where R2 has the same meaning as above and, if R,' stands for a benzyl group, this is cleaved off reductively and the secondary amino group formed is optionally alkylated.

Forbindelser med formel I, hvor R,, står for hydrogen, oppnås også, etter en variant av fremgangsmåten, ved at forbindelsen med formel V underkastes hydrolyse, dekarboksyleninig og forestring med en alkohol bare i kort tid, hvorved det dannes et substituert ravsyre-alkyl-ester-amid som ved oppvarming til over smeltepunktet eller ved koking i et opp-løsningsmlddel går over 1 et succinimid som Ikke er substituert ved nitrogenatomet. Compounds of formula I, where R,, stands for hydrogen, are also obtained, according to a variant of the method, by subjecting the compound of formula V to hydrolysis, decarboxylation and esterification with an alcohol only for a short time, whereby a substituted succinic alkyl is formed -ester amide which, when heated to above the melting point or when boiled in a solvent, undergoes a succinimide which is not substituted at the nitrogen atom.

Fremstillingen av det succinimid (formel I: R, = H) som Ikke er substituert ved piperidinnitrogenet foregår fortrinsvis over (1-benzyl-piperldyl-4)-forbindelsene med 'tilsluttende reduktiv avspalting av benzylgruppen. Til den katalytiske deben-zylering, f. eks. med hydrogen/palladium, kan både saltene og de fri baser anvendes. Succinimid-derivatet kan så alkyleres ved piperidin-nlitrogenatomet, idet det behand-les f. eks. med et lavere alifatisk aldehyd eller keton i hydrogenatmosfære i nærvær av en katalysator, eller med et alkylhalo-genid, fortrinsvis i nærvær av et alkalisk kondenserlngsmiiddel, f. eks. natriumkarbonat, eller også metyleres ved behandling med formaldehyd/maursyre. The preparation of the succinimide (formula I: R, = H) which is not substituted at the piperidine nitrogen preferably takes place over the (1-benzyl-piperidyl-4) compounds with subsequent reductive removal of the benzyl group. For the catalytic deben-zylation, e.g. with hydrogen/palladium, both the salts and the free bases can be used. The succinimide derivative can then be alkylated at the piperidine nitrogen atom, as it is treated e.g. with a lower aliphatic aldehyde or ketone in a hydrogen atmosphere in the presence of a catalyst, or with an alkyl halide, preferably in the presence of an alkaline condensing agent, e.g. sodium carbonate, or is also methylated by treatment with formaldehyde/formic acid.

Fremgangsmåten blir eksempelvis ut-ført på følgende måte: Et l-alkyl-piperidon-4 i et inert or-ganisk oppløsningsmiddel, f. eks. benzol, toluol, xylol, tetraiin osv. omsatt med en forbindelse med formel III, fortrinsvis med en cyaneddåksyre-alkyl-ester, i nærvær av en vannavspaltende katalysator, f. eks. iseddik alene eller sammen med ammondumacetat, og under 'anvendelse av en kontinuerlig arbeidende vannutskiller, til en forbindelse med formel IV. Ved dobbelt-bindingen av dette derivat blir det tilleiret blåsyre, og den forbindelse med formel V som dannes blir forsåpet og dekarfaofcsylert med kons. saltsyre til en substituert ravsyre. Denne blir forestret med en abs. alkohol og klorhydrogen til en substituert ravsyre-diester med formel VI. Fremgangsmåten frem til diesteret med formel VI blir fortrinsvis gjennomført uten isolering henholdsvis rensing av de enkelte mellom-produkter. The method is carried out, for example, in the following way: A 1-alkyl-piperidone-4 in an inert organic solvent, e.g. benzene, toluene, xylol, tetrayl, etc. reacted with a compound of formula III, preferably with a cyanoacetic acid alkyl ester, in the presence of a water splitting catalyst, e.g. glacial acetic acid alone or together with ammondum acetate, and using a continuously operating water separator, to a compound of formula IV. During the double bond of this derivative, prussic acid is added, and the compound of formula V that is formed is saponified and decarfaofcylated with conc. hydrochloric acid to a substituted succinic acid. This is esterified with an abs. alcohol and hydrogen chloride to a substituted succinic acid diester of formula VI. The process up to the diester of formula VI is preferably carried out without isolation or purification of the individual intermediate products.

Det substituerte ravsyre-diester med formel VI kan nu overføres til det ønskete substituerte succinimid med formel I ved omsetning med kons. vandig ammoniakk eller at primært alkylamin, f. eks. flytende metylamin, etylamin osv., fortrinsvis i luk-ket kar. Da det 1 det siste reaksjonstrinn først dannes et substituert ravsyre-diamid-derivat, må reatosjonsblandingen for å opp-nå ringslutn-ing av diamidet tilslutt oppvarmes til høy temperatur, f. eks. 180— 250°. The substituted succinic diester of formula VI can now be transferred to the desired substituted succinimide of formula I by reaction with conc. aqueous ammonia or that primary alkylamine, e.g. liquid methylamine, ethylamine etc., preferably in a closed vessel. As a substituted succinic acid-diamide derivative is first formed in the last reaction step, the reaction mixture must finally be heated to a high temperature to achieve ring closure of the diamide, e.g. 180— 250°.

De nye substituerte succinimider med formel I er farveløse forbindelser, som ved romtemperatur er oljeaktige eller faste krystallinske. De lar seg lett oppløse i van-lige organiske oppløsningsmidler, men ikke i vann. Med anorganiske eller organiske syrer danner de stabile salter som er krystallinske ved romtemperatur og som lett lar seg oppløse i vann. The new substituted succinimides of formula I are colorless compounds, which at room temperature are oily or solid crystalline. They dissolve easily in common organic solvents, but not in water. With inorganic or organic acids, they form stable salts which are crystalline at room temperature and which can easily dissolve in water.

De nye forbindelser har Interessante, terapeutisk verdifulle, farmakodynamiske egenskaper, som delvis skyldes en cholin-ergisk virkningstype. Således utmerker f. eks. spiro- (l-metyl-plperidyl-4) -N-metyl-succinimM og det tilsvarende -N-etyl-suc-cinlmid seg ved en omfattende parasym-påtikomimetisk virkning, som ytrer seg perifert eller sentralt. De virker blodtrykk-senkende og pulsfrekvens-senkende på dyr. Samtidig øker motiliteten for tynntarmen og urinblæren og spyttfloden samt mave-saf tsekresj onen blir fremmet sterkt. De sentrale cholinergiske effekter ytrer seg i en utpreget narkosepotensering, en tydelig analgesi samt i en hemning av betingete reflekser. Det dreier seg herunder om pa-rasympatikomimetiske effekter, da også de sentrale virkninger blir hemmet eller opphevet ved hjelp av store doser av hy-oscyamin og andre sentralt virkende an-tichollnergika. På grunn av sine opphis-sende egenskaper på mavetarmvirksomhe-ten og urinblærefunksj onen skal de nye forbindelser 'brukes for behandling av mave-og tarm-sykdommer samt innføres 1 uro-logien. Samtidig kan de torukes for berolig-else og for 'behandling av psykiske forstyr-relser samt av smertetilstander. De utgjør videre verdifulle 'mellomprodukter for fremstilling av medikamenter. The new compounds have interesting, therapeutically valuable, pharmacodynamic properties, which are partly due to a cholinergic mode of action. Thus, e.g. spiro-(1-methyl-plperidyl-4)-N-methyl-succinimide and the corresponding -N-ethyl-succinimide by an extensive parasympathomimetic action, which manifests itself peripherally or centrally. They have a blood pressure-lowering and pulse-rate-lowering effect on animals. At the same time, the motility of the small intestine and urinary bladder increases and the flow of saliva and gastric juice secretion are strongly promoted. The central cholinergic effects manifest themselves in a pronounced potentiation of anesthesia, a clear analgesia and in an inhibition of conditioned reflexes. These include parasympathomimetic effects, as the central effects are also inhibited or abolished by means of large doses of hyoscyamine and other centrally acting anticholinergics. Due to their stimulating properties on gastrointestinal activity and urinary bladder function, the new compounds are to be used for the treatment of gastrointestinal diseases and introduced into urology. At the same time, they can be used for sedation and for the treatment of mental disorders as well as pain conditions. They also constitute valuable 'intermediate products for the manufacture of drugs.

Det skal nu gis noen eksempler på hvorledes fremgangsmåten kan gjennom-føres, idet herunder alle temperaturer er angitt i celsiusgrader. Smelte- og koke-punktene er ikke korrigert. Some examples will now be given of how the method can be carried out, with all temperatures being indicated in degrees Celsius. The melting and boiling points are not corrected.

Eksempel 1. Example 1.

Spiro-( l- metyl- piperidyl- 4) - succinimid. Spiro-(1-methyl-piperidyl-4)-succinimide.

(8-metyl-2,8-diazasplro [4,5] dekan-1,3-dion) a) ( 1 - metyl- piperidyliden- 4)- cyaneddiksyre- etylester. (8-methyl-2,8-diazaspro [4,5] decane-1,3-dione) a) (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester.

113,0 ig cyanetidiksyre-etylester, 113,0 g l-metyl-piperldon-4 og 23 ems iseddik ble 113.0 ig of cyanoethylacetic acid ethyl ester, 113.0 g of 1-methyl-piperldone-4 and 23 ems of glacial acetic acid were

kokt i fire timer i 250 ems benzol. Det vann som tole uvspaltet under reaksjonen ble fjernet kontinuerlig fra tiltoakeløpet ved hjelp av en vannutskiller. Etter 2i/2 time var det spaltet av 18 ems vann. Etter ytterligere l>/2 times koking ble det satt ytterligere 300 ems toenzol til og det hele ble rystet ut med 150 cm3 Iskold mettet pottaskeoppløsning. Pobtaskeoppløsnlngen ble ekstrahert ennu en gang med 150 ems benzol og toenzolekstrakten vasket en gang med 50 ems vann. Ettertørking over na-triumisulfat ble de forente toenzolekstrakter dampet av og den mørkfarvete kolberest destillert forsiktig i høyvakuum. Bare en liten overheting, f. eks. ved destilleringen bevirket betraktelig spalting. Rent (1 -metyl-piperidyliden-4) -cyaneddiksyreetyl-ester er en farveløs, viskos olje med kp. boiled for four hours in 250 ems benzol. The water which was separated during the reaction was removed continuously from the tillage run by means of a water separator. After 2½ hours there was a gap of 18 ems of water. After a further 1/2 hour of boiling, a further 300 ems toenzol was added and the whole was shaken out with 150 cm3 of ice-cold saturated pot ash solution. The pobash solution was extracted once more with 150 ems of benzene and the toluene extract washed once with 50 ems of water. After drying over sodium sulphate, the combined toenzole extracts were evaporated and the dark-coloured cob residue was carefully distilled in high vacuum. Just a little overheating, e.g. during the distillation caused considerable cleavage. Pure (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester is a colorless, viscous oil with bp.

114—115°/0,05 mm Hg ,n <2>^'<5>= 1,4952. 114—115°/0.05 mm Hg ,n <2>^'<5>= 1.4952.

Hydrokloridet danner fine nåler med smp. 182—183° (sp) fra etanol. b) [( lmetyl- 4- karbetoksy- piperidyl)- 4] eddiksyre- etylester. 87,3 g (1-metyl-piperidyliden-4)-cyaneddiksyre-etylester og 42,5 g kaliumcyanid ble varmet opp på vanntoad sammen med 130 cm» 50 pst. etanol. Etter 10 min. ble det satt til ytterligere 15 ems vann og det hele fikk stå 1 ennu 5 min. på vannbadet. Oppløsningen som nu var klar, orangefar-vet ble kjølet til romtemperatur og under iskjøling tole det tilsatt 80 cm3 kons. saltsyre. Oppløsningen ble Inndampet ved vannstrålevakuum ved 60° til tørr tilstand, resten ble opptatt i 150 ems vann og den vandige oppløsning tole mettet med klorhydrogengass under iskjøling. Så ble det foretatt koking i 20 timer ved tilbakeløp og ny inndamping til tørr tilstand. Den farveløse, krystallinske rest ble tørket i 60 timer over fosforpentofcsyd, oppslem-met i 500 cm» etanol som var tørket over kalsiumoksyd og oppslemmingen mettet under iskjøling med tørr klorhydrogengass og kokt i 15 timer ved tilbakeløp. Deretter ble det foretatt inndamping 1 nitrogenat-mosfære ved vannstrålevakuum ved 60° til <i>/4 av det opprinnelige volum, fortynning under god kjøling med den dobbelte mengde vann, metting med kaliumkarbonat og ekstrahering 3 ganger hver gang med 250 ems kloroform. Kloroformekstraktene ble vasket en gang med vann og tørket over natriumsulfat. Etter fordamping av klo-roformen tole den oljeaktige kolberest destillert i høyvakuum. Ren [(l-metyl-4-karbetoksy-piper idyl) -4] -eddiksyre-etyl ester er en f arveløs olje med kp. 95—96/ 20 *i The hydrochloride forms fine needles with m.p. 182-183° (mp) from ethanol. b) [(1methyl-4-carbethoxy-piperidyl)-4]acetic acid ethyl ester. 87.3 g of (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester and 42.5 g of potassium cyanide were heated on a water bath together with 130 cm" of 50% ethanol. After 10 min. a further 15 ems of water was added and the whole thing was allowed to stand for 1 more 5 min. in the water bath. The solution, which was now clear and orange in colour, was cooled to room temperature and, under ice cooling, 80 cm3 conc. hydrochloric acid. The solution was evaporated by water jet vacuum at 60° to a dry state, the residue was taken up in 150 ems of water and the aqueous solution was saturated with chlorine hydrogen gas under ice cooling. Boiling was then carried out for 20 hours at reflux and further evaporation to dryness. The colorless, crystalline residue was dried for 60 hours over phosphorus pentofcyde, slurried in 500 cc of ethanol which had been dried over calcium oxide and the slurry saturated under ice-cooling with dry chlorine hydrogen gas and boiled for 15 hours at reflux. Evaporation was then carried out in 1 nitrogen atmosphere under a water jet vacuum at 60° to <i>/4 of the original volume, dilution under good cooling with double the amount of water, saturation with potassium carbonate and extraction 3 times each time with 250 ems chloroform. The chloroform extracts were washed once with water and dried over sodium sulfate. After evaporation of the chloroform, the oily residue is distilled under high vacuum. Pure [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid-ethyl ester is a colorless oil with bp. 95—96/ 20 *i

0,06 mm Hg. n ^ = 1,4582. Pikrat. Ka-narigule nåler fra etanol, smp. 135—136°. 0.06 mmHg. n ^ = 1.4582. Pikrat. Canary yellow needles from ethanol, m.p. 135-136°.

c) Spiro-( l- metyl- piperidyl- 4)- succinimid 6,6 g [(l-metyl-4-karbetoksy-piperidyl)-4]-eddiksyreetylester ble kokt sammen med 50 cm3 kons. vandig ammoniakk i 46 timer ved tilbakeløp. Etter 5 timer var c) Spiro-(1-methyl-piperidyl-4)-succinimide 6.6 g [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester was boiled together with 50 cm3 conc. aqueous ammonia for 46 hours at reflux. After 5 hours was

den opprinnelig uoppløste ester gått full-stendig i oppløsning. Den svakt gulfarvete reaksj onsoppløsning ble inndampet til tørr tilstand ved vannstrålevakuum ved 60° til tørr tilstand. Den krystallinske kolberest ble så oppvarmet i 3 timer til 200°, så opptatt i vann og filtrert gjennom vatt. Filtratet ble inndampet til tørr tilstand og kolberesten oppløst i metanol. Oppløsningen ble iblandet med tørr brom-hydrogengass, hvorunder hydrobromidet av det søkte spiro-(l-metyl-piperidyl-4)-succinimid tole felt ut i farveløse små pla-ter. Etter omkrystallisering fra metanol smeltet det svakt hygroskopiske hydrobromid ved 311—313° (sp). the originally undissolved ester has completely dissolved. The slightly yellow reaction solution was evaporated to dryness under a water jet vacuum at 60° to dryness. The crystalline flask residue was then heated for 3 hours at 200°, then taken up in water and filtered through cotton wool. The filtrate was evaporated to dryness and the carbon residue dissolved in methanol. The solution was mixed with dry bromine-hydrogen gas, during which the hydrobromide of the desired spiro-(1-methyl-piperidyl-4)-succinimide tole precipitated in colorless small plates. After recrystallization from methanol, the slightly hygroscopic hydrobromide melted at 311-313° (sp).

Eksempel 2. Example 2.

Spiro- ( 1 - metyl- piperidyl- 4) - N-metyl- succinimid. Spiro-(1-methyl-piperidyl-4)-N-methyl-succinimide.

(2,8-dimetyl-2,8-diazaspiro [4,5] de-kan-l,3-dion). (2,8-dimethyl-2,8-diazaspiro[4,5]decane-1,3-dione).

Først tole det fremstilt (1-metyl-piper-idyllden-4) -cyaneddiiksyre-etylester slik som angitt 1 eksempel 1 under a) og over-ført til [ (l-metyl-4-karbetofcsy-piperidyl)-4]-eddiksyreetylester slik som angitt i eksempel 1 under b). 59,5 g av denne ester ble oppvarmet sammen med et overskudd av flytende 100 pst. metylamin i 12 timer i trykk-kar ved 140°. Så tole det foretatt avkjøling og overskuddet av metylamin fikk fordampe. Den krystallinske kolberest tole oppvarmet til 185°, hvorunder metylamin ble avspaltet under smelting. Etter 2i/2 time var metylaminutvlkllngen avslut-tet. Ved avkjølingen utkrystalliserte kolberesten. Den ble opptatt i 2-n. saltsyre, ekstrahert med eter og den saltsure oppløs-ning gjort alkalisk ved tilsetting av fast kaliumkarbonat. Det ibunnfall som herunder ble dannet ble ekstrahert med metyl-enklorid, uttrkket vasket en gang med vann og tørket over natriumsulfat. Etter fordampning av oppløsningsmiddelet ble det tilbake en farveløs, krystallinsk rest av spiro-(l-metyl-piperidyl-4)-N-metyl-suc-cinimld. Forbindelsen lar seg lett subli-mere med «utolimerlngspunkt 80°/0,01 mm Hg, smp. 94—96°. First, the prepared (1-methyl-piper-idylden-4)-cyanoacetic acid ethyl ester as indicated in Example 1 under a) and transferred to [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester as stated in example 1 under b). 59.5 g of this ester were heated together with an excess of liquid 100% methylamine for 12 hours in a pressure vessel at 140°. Cooling was then carried out and the excess methylamine was allowed to evaporate. The crystalline carbon residue was heated to 185°, below which methylamine was split off during melting. After 2½ hours the methylamine evolution was complete. During cooling, the carbon residue crystallized. It was occupied in 2-n. hydrochloric acid, extracted with ether and the hydrochloric acid solution made alkaline by the addition of solid potassium carbonate. The precipitate that formed below was extracted with methylene chloride, extracted, washed once with water and dried over sodium sulfate. After evaporation of the solvent, a colorless, crystalline residue of spiro-(1-methyl-piperidyl-4)-N-methyl-succinyl was left. The compound can be easily sublimated with a melting point of 80°/0.01 mm Hg, m.p. 94-96°.

Hydrokloridet som ble fremstillet i etanol ble omkrystallisert fra metanol; svakt hygroskopiske, farveløse prismer med smp. 318—319° (sp). The hydrochloride prepared in ethanol was recrystallized from methanol; weakly hygroscopic, colorless prisms with m.p. 318—319° (sp).

Fumarat: Ekvivalente mengder av succinimid-derivatet og fumarsyre (1 mol : 1 mol) hie kokt opp sammen i etanol. Etter avkj øling ble det foretatt filtrering og krystallisering fra metanol/vann. Farveløse polyeder med smp. 266° (sp). Fumarate: Equivalent quantities of the succinimide derivative and fumaric acid (1 mol : 1 mol) were boiled together in ethanol. After cooling, filtration and crystallization from methanol/water were carried out. Colorless polyhedra with m.p. 266° (sp).

Pikrat: Overskytende etanolisk pik-rinsyreoppløsning ble kokt opp i kort tid sammen med sucoinimidderivatet. Ved av-kjøling utkrystalliserte pikratet i fine gule prismer. Omkrystallisering fra etanol/ vann. Smp. 260° (sp) etter sintring ved 216°. Picrate: Excess ethanolic picric acid solution was boiled for a short time together with the sucoinimide derivative. On cooling, the picrate crystallized in fine yellow prisms. Recrystallization from ethanol/water. Temp. 260° (sp) after sintering at 216°.

Eksempel 3. Example 3.

Spiro- ( l- metyl- piperidyl- 4) - N-etyl- succinimid. Spiro-(1-methyl-piperidyl-4)-N-ethyl-succinimide.

(2-etyl-8-metyl-2,8-diazasplro [4,5] dekan-l,3-dion). (2-ethyl-8-methyl-2,8-diazaspro[4,5]decane-1,3-dione).

Først ble [(l-metyl-4-karbetoksy-piperidyl) -4] -eddiksyreetylester fremstillet slik som angitt 1 eksempel 1 under a) og to). First, [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester was prepared as indicated in Example 1 under a) and two).

15,0 g av denne ester tole oppvarmet sammen med 15 cm» etylamin 1 40 timer i igjensmeltet rør til 150°. Det overskytende amin ble fordampet i vannstrålevakuum ved 40° og det utkrystalliserte råprodukt destillert 1 høyvakuum. Spiro-(l-metyl-piperidyl-4)-N-etyl-succinimid kokte ved 79° under 0,04 mm Hg. 15.0 g of this ester were heated together with 15 cm" of ethylamine 1 for 40 hours in a remelted tube to 150°. The excess amine was evaporated in a water jet vacuum at 40° and the crystallized crude product distilled under high vacuum. Spiro-(1-methyl-piperidyl-4)-N-ethyl-succinimide boiled at 79° under 0.04 mm Hg.

Hydrokloridet ble oppnådd ved å tolan-de den alkaliske oppløsning av den fri toase med en oppløsning av etanolisk saltsyre. Fra etanol farveløse prismer med smp. 255°. The hydrochloride was obtained by diluting the alkaline solution of the free toase with a solution of ethanolic hydrochloric acid. From ethanol colorless prisms with m.p. 255°.

Hydrobromidet tole oppnådd på tilsvarende måte og smeltet ved 302—304° etter omkrystallisering fra etanol. The hydrobromide tole obtained in a similar manner and melted at 302-304° after recrystallization from ethanol.

Fumarat: En konsentrert vandig opp-løsning av -fumarsyre tole blandet med en ekvivalent mengde av succinimidderivatet (1 mol : 1 mol). Det tole tilsatt litt etanol og den f arveløse oppløsning tole inndampet til tørr tilstand. Resten tole omkrystallisert fra etanol/vann. Farveløse polyeder med smp. 204—206°. Fumarate: A concentrated aqueous solution of -fumaric acid tole mixed with an equivalent amount of the succinimide derivative (1 mol : 1 mol). A little ethanol was added to it and the colorless solution was evaporated to dryness. The residue tole recrystallized from ethanol/water. Colorless polyhedra with m.p. 204—206°.

Pikrat: Overskytende etanol.sk pikrin-syreoppløsning tole satt til det fri succlni-mid-derivat og kokt opp i kort tid. Etter avkjøling tole det foretatt avfiltrering og omkrystallisering tre ganger fra etanol/ vann. Smp. 214—217°. Picrate: Excess ethanol.sk picric acid solution tole added to the free succlnimid derivative and boiled for a short time. After cooling, filtration and recrystallization were carried out three times from ethanol/water. Temp. 214—217°.

Eksempel 4. Example 4.

Spiro- ( piperidyl- 4 ) - N'- metyl- succinimid. Spiro-(piperidyl-4)-N'-methyl-succinimide.

2-metyl-2,8-diazaspiro [4,5] dekan-1,3-dion). a) ( l- bemyl- piperidyliden- 4) - cyaneddiksyre- etylester. 50 g cyaneddiksyre-etylester, 70,48 g 1-benzyl-piperidon-4, 12 ems iseddik og 4 g ammondumacetat tole kokt sammen 1 400 ems benzol i 7 timer ved tilbakeløp. Det vann som tole dannet tole fjernet kontinuerlig fra tiltoakeløpet ved hjelp av an vann-avskiller. Etter 7 timer var det spaltet av 7 cm?>.Reaksj onsblandingen ble,etter å væ-re avkjølet med isvann, rystet ut en gang med mettet pottaskeoppløsning og den vandige fase ettervasket en gang med benzol. De forente benzollag ble vasket en gang med vann, tørket over natriumsulfat og inndampet. Den mørkfarvete kolberest, som bestod av rå (1-toenzyl-piperidyliden-4) -cyaneddiksyre-etylester, utkrystalliserte fullstendig ved avkjøling. Este-ren kan anvendes direkte uten ytterligere rensing. Fra eter/petroleter dannet den gulf arvete krystaller med smp. 70—71°. 2-methyl-2,8-diazaspiro[4,5]decane-1,3-dione). a) (l-bemyl-piperidylidene-4)-cyanoacetic acid ethyl ester. 50 g cyanoacetic acid ethyl ester, 70.48 g 1-benzyl-piperidone-4, 12 ems glacial acetic acid and 4 g ammondum acetate were boiled together in 1,400 ems benzene for 7 hours at reflux. The water that formed tole was continuously removed from the tillage run by means of a water separator. After 7 hours, it was separated by 7 cm?>. The reaction mixture was, after being cooled with ice water, shaken out once with a saturated potash solution and the aqueous phase washed once with benzene. The combined benzene layers were washed once with water, dried over sodium sulfate and evaporated. The dark-colored carbon residue, which consisted of crude (1-toenzyl-piperidylidene-4)-cyanoacetic acid ethyl ester, completely crystallized on cooling. The ester cleaner can be used directly without further purification. From ether/petroleum ether it formed yellow crystals with m.p. 70-71°.

to) [ ( 1 - benzyl- 4- karbetoksy- piper idyl)-4]- eddiksyre- etylester. two) [ ( 1 - benzyl- 4- carbethoxy-piperidyl)-4]- acetic acid ethyl ester.

Ovenstående kolberest tole oppløst i 500 cm3 etanol, 250 cm3 vann tole tilsatt og oppløsningen oppvarmet på kokende vanntoad. Under oppvarmingen ble det tilsatt 31 g kalsiumcyanid som straks opp-løser seg ved omrøring. Etter at alt var oppløst, ble temperaturen holdt på 75° i 12—15 min., hvoretter 250 cm3 2-n. saltsyre tole tilsatt og oppløsningen inndampet ved vannstrålevakuum til tørr tilstand. Deretter ble det tilsatt 750 cm3 HC1, kokt i 14 timer ved tilbakeløp, avkjølet og filtrert. Filtratet tole inndampet til tørr tilstand og koltoeresten og filterresten tør-ket 1 60 timer over fosforpentoksyd. Om den tørkete krystallmasse ble det så helt 500 ems etanol og under iskjøling ble det innført klorhydrogengass Inntil metning. Det tole foretatt koking i 18 timer ved til-bakeløp, reaksj onsblandingen ble avkjølt og filtrert. Filtratet tole igjen inndampet til tørr tilstand, koltoeresten og filterresten ble oppløst i isvann og et overskudd av pottaske ble satt til oppløsningen. Så tole det foretatt ekstrahering tre ganger med eter og eterekstraktene tole vasket hver gang med vann. Etter at eterekstrakten var tørket over natriumsulfat ble den inndampet og den oljeaktige kolberest tole destillert i kulerør. [(l-benzyl-4Jkarbetoksy-piperidyl)-4]-eddiksyre-etylester kokte ved 150° under 0,03 mm Hg (temperatur målt i luftbadet); svakt gulf arvet olje. c) Spiro-( benzyl- piperidyl- 4) - N- metyl-succinimid. The above cob residue was dissolved in 500 cm3 of ethanol, 250 cm3 of water was added and the solution was heated over boiling water. During the heating, 31 g of calcium cyanide was added, which immediately dissolves on stirring. After everything had dissolved, the temperature was kept at 75° for 12-15 min., after which 250 cm3 2-n. hydrochloric acid tole added and the solution evaporated by water jet vacuum to dryness. Then 750 cm 3 of HC1 were added, boiled for 14 hours at reflux, cooled and filtered. The filtrate was evaporated to dryness and the carbon residue and the filter residue were dried over phosphorus pentoxide for 160 hours. About the dried crystal mass, 500 ems of ethanol were added and, under ice cooling, chlorine hydrogen gas was introduced until saturation. Boiling was carried out for 18 hours at reflux, the reaction mixture was cooled and filtered. The filtrate was again evaporated to dryness, the charcoal residue and the filter residue were dissolved in ice water and an excess of pot ash was added to the solution. Extraction was then carried out three times with ether and the ether extracts were washed each time with water. After the ether extract had been dried over sodium sulphate, it was evaporated and the oily cob residue was distilled in a ball tube. [(1-Benzyl-4H-carbethoxy-piperidyl)-4]-acetic acid ethyl ester boiled at 150° below 0.03 mm Hg (temperature measured in the air bath); weak gulf inherited oil. c) Spiro-(benzyl-piperidyl-4)-N-methyl-succinimide.

15,0 g [(l-benzyl-4-kartoetoksy-piperidyl)-4]-eddiksyreetylester tole oppvarmet sammen med et overskudd av flytende metylamin i 12 timer 1 stålautoklav ved 180°. Det overskytende metylamin tole så fordampet og den krystallinske kolberest oppvarmet i ytterligere 4 timer til 200°, inntil produktet, som var smeltet ved denne temperatur, ikke viste ytterligere tolæredan-nelse. Stoffet tole opptatt i litt etanol, kokt i kort tid med litt aktivt kull og filtrert. Ved avkjøling ble spiro-(1 -toenz<y>l-<p>iperid-yl-4)-N-metyl-succinimid utfelt i store farveløse prismer med smp. 111—112°. 15.0 g of [(1-benzyl-4-cartoethoxy-piperidyl)-4]-acetic acid ethyl ester were heated together with an excess of liquid methylamine for 12 hours in a steel autoclave at 180°. The excess methylamine tole was then evaporated and the crystalline carbon residue heated for a further 4 hours at 200°, until the product, which had melted at this temperature, showed no further tole formation. The substance tole absorbed in a little ethanol, boiled for a short time with a little activated charcoal and filtered. On cooling, spiro-(1-toenz<y>l-<p>iperid-yl-4)-N-methyl-succinimide was precipitated in large colorless prisms with m.p. 111-112°.

Hydroklorid. Fra etanol farveløse prismer med smp. 254—256°. d) Spiro-( piperidyl- 4)- N- metyl-succinimid. Hydrochloride. From ethanol colorless prisms with m.p. 254—256°. d) Spiro-(piperidyl-4)-N-methyl-succinimide.

3,0 g spiro-(l-benz<y>l-piiperidyl-4)-N-metyl-succinimid i 100 cm?> etanol tole hy-drert med 300 mg palladium på aktivt kull (10 pst.) i 12 timer under normaltrykk ved romtemperatur. Hydrogenopptagelsen var 315 cma (= 114 pst.). Etter at etanolet var fordampet ble det rå spiro-(piperidyl-4)-N-metyl-succinimid destillert i kulerør i høyvakuum kp. 99°/0,02 mm Hg (temperatur målt i luftbadet). Det var et sterkt hygroskopisk stoff som krystalliserte i rett-vinklete prismer med smp. 67°. 3.0 g of spiro-(l-benz<y>l-piperidyl-4)-N-methyl-succinimide in 100 cm?> ethanol tole hydrated with 300 mg of palladium on activated carbon (10 percent) for 12 hours under normal pressure at room temperature. The hydrogen uptake was 315 cma (= 114 per cent). After the ethanol had evaporated, the crude spiro-(piperidyl-4)-N-methyl-succinimide was distilled in a ball tube in high vacuum bp. 99°/0.02 mm Hg (temperature measured in the air bath). It was a strongly hygroscopic substance that crystallized in right-angled prisms with m.p. 67°.

Hydrobromid: Sammenfiltrete, fine nåler med smp. 292—294° etter omkrystallisering fra etanol/vann. Hydrobromide: Entangled, fine needles with m.p. 292—294° after recrystallization from ethanol/water.

Eksempel 5. Example 5.

Spiro- ( piperidyl- 4)- succinimid. Spiro-(piperidyl-4)-succinimide.

(2,8-diazaspiro-[4,5]-dekan-l,3-dion). a) Spiro-( l- benzyl- piperidyl- 4)-succinimid. (2,8-diazaspiro-[4,5]-decane-1,3-dione). a) Spiro-(1-benzyl-piperidyl-4)-succinimide.

Etter samme fremgangsmåte som er beskrevet i eksempel 4, under a) ble det først fremstilt (l-toenzyl-plperidyliden-4)-cyan-eddiksyre-etylester. Gule krystaller med smp. 70—71° fra eter-petroleter. Following the same procedure as described in example 4, under a), (1-thoenzyl-plperidylidene-4)-cyano-acetic acid ethyl ester was first prepared. Yellow crystals with m.p. 70—71° from ether-petroleum ether.

Blåsyretilleiringen foregikk ved behandling med alkalicyanid slik som beskrevet i eksempel 4 under to). Det ble nu foretatt forsåpning med kons. saltsyre i bare 3 timer (det blir ikke lenger konsta-tert kulldioksydutvikling). Etter avkjøling ble det foretatt filtrering, filtratet ble inndampet til tørr tilstand og resten tørket godt over fosforpentoksyd. Forestringen foregikk med etanol/klorhy drogen ved romtemperatur. Reaksj onsbliandingen ble inndampet til tørr tilstand, resten opptatt i litt vann, gjort alkalisk med pottaske under iskjøling og ekstrahert med kloroform. Kloroformekstrakten ble konsentrert, hvorunder forbindelsen, som var befridd for oppløsningsmlddelet, utkrystalliserte. Det dreiet seg om [(l-benzyl-4-karbamoyl-piperidyl)-4]-eddifcsyre-etylester som ved oppvarming over smeltepunktet gikk over i det ønskete spiro-(l-toenzyl-piperidyl-4)-succinlmid. Smp. 185° etter krystallisering fra etanol. Hydroklorid: smp. 312° (sp) etter krystallisering fra etanol. The hydrocyanic acid deposition took place by treatment with alkali cyanide as described in example 4 under two). Saponification was now carried out with conc. hydrochloric acid for only 3 hours (carbon dioxide evolution is no longer detected). After cooling, filtration was carried out, the filtrate was evaporated to dryness and the residue was dried well over phosphorus pentoxide. The esterification took place with ethanol/hydrogen chloride at room temperature. The reaction mixture was evaporated to dryness, the residue taken up in a little water, made alkaline with pot ash under ice cooling and extracted with chloroform. The chloroform extract was concentrated, during which the compound, freed from the solvent, crystallized. It was about [(1-benzyl-4-carbamoyl-piperidyl)-4]-acetic acid ethyl ester which, when heated above the melting point, converted into the desired spiro-(1-thobenzyl-piperidyl-4)-succinimide. Temp. 185° after crystallization from ethanol. Hydrochloride: m.p. 312° (sp) after crystallization from ethanol.

b) Spiro- ( piperidyl- 4) - succinimid. b) Spiro-(piperidyl-4)-succinimide.

En forbindelse som er oppnådd slik A compound thus obtained

som beskrevet ovenfor ble underkastet en katalytisk hydrering for å spalte av benzylgruppen. Hydrerlngen ble foretatt slik som beskrevet i eksempel 4 under d). Spiro-(piperidyl-4)-succinimid smeltet ved 243—244° (sp) etter omkrystallisering fra etanol. Hydroklorid: smp. 356° (sp) etter omkrystallisering fra etanol/vann. as described above was subjected to a catalytic hydrogenation to cleave off the benzyl group. The hydrogenation was carried out as described in example 4 under d). Spiro-(piperidyl-4)-succinimide melted at 243-244° (sp) after recrystallization from ethanol. Hydrochloride: m.p. 356° (sp) after recrystallization from ethanol/water.

Eksempel 6. Example 6.

Spiro- ( l- etyl- piperidyl- 4) - N-etyl- succinimid. Spiro-(1-ethyl-piperidyl-4)-N-ethyl-succinimide.

(2,8-dietyl-2,8-diazaspiro[4,5]dekan-1,3-dion). (2,8-diethyl-2,8-diazaspiro[4,5]decane-1,3-dione).

Først ble det fra [(l-benzyl-4-karbetoksy-piper idyl) -4]-eddiksyre-etylester og etylamin fremstillet spiro- (1-toenzyl-piperidyl-4)-N-etyl-succinimid etter samme fremgangsmåte som den som er beskrevet i eksempel 4. Smp. 104—105° etter omkrystallisering fra etanol. First, spiro-(1-toenzyl-piperidyl-4)-N-ethyl-succinimide was prepared from [(1-benzyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester and ethylamine using the same procedure as that which is described in example 4. Smp. 104—105° after recrystallization from ethanol.

Avspaltingen av benzylgruppen foregikk på lignende måte som i foregående eksempel og førte til spiro-(piperidyl-4)-N-etyl-succinimid. Meget seig olje med smp. 107°/0,05 mm Hg. Forbindelsen krystalliserte ikke. The cleavage of the benzyl group took place in a similar manner as in the previous example and led to spiro-(piperidyl-4)-N-ethyl-succinimide. Very viscous oil with m.p. 107°/0.05 mm Hg. The compound did not crystallize.

13 g av forbindelsen, 25 ems nydestil-lert acetaldehyd, 75 cm?- etanol og 3 g Ra-neynikkel ble rystet i 24 timer under hydrogenatmosfære ved normaltrykk og romtemperatur. Det ble utført filtrering fra katalysatoren, oppløsningsmiddelet ble dampet av og resten ble destillert under nedsatt trykk. Den fraksj on som gikk over ved 132°/0,2 mm Hg dannet spiro-(l-etyl-piperidyl-4) -N-etyl-succinimid. Hydrobromidet smeltet ved 293° etter omkrystallisering fra metanol. 13 g of the compound, 25 ems of freshly distilled acetaldehyde, 75 cm3 ethanol and 3 g Raney nickel were shaken for 24 hours under a hydrogen atmosphere at normal pressure and room temperature. Filtration from the catalyst was carried out, the solvent was evaporated and the residue was distilled under reduced pressure. The fraction that transitioned at 132°/0.2 mm Hg formed spiro-(1-ethyl-piperidyl-4)-N-ethyl-succinimide. The hydrobromide melted at 293° after recrystallization from methanol.

Eksempel 7. Example 7.

Spiro- ( l- n- butyl- piperidyl- 4) - Spiro-(l-n-butyl-piperidyl-4)-

N- etyl- succinimid. N-ethyl succinimide.

(2-etyl-8-n-butyl-2,8-diazaspiro [4,5]dekan-l,3-dion). (2-ethyl-8-n-butyl-2,8-diazaspiro[4,5]decane-1,3-dione).

3,10 g spiro-(piperidyl-4)-N-etyl-suc- 3.10 g of spiro-(piperidyl-4)-N-ethyl-suc-

cinimid, fremstilt slik som beskrevet i eksempel 6 tole oppvarmet sammen med 2,17 g n-butyltoromid og 5 g natriumkarbonat i 25 ems n-toutanol i 24 timer ved tilbake-løp. Reaksj onsblandingen tole inndampet til tørr tilstand og resten opptatt i 2-n. saltsyre under kjøling. Den sure oppløs-ning ble rystet ut en gang med eter, gjort alkalisk med pottaske og ekstrahert med eter. Fra eterekstrakten tole hydrokloridet av spiro- (l-n-butyl-piperidyl-4) -N-etyl-succinimid fremstillet ved tilsetning av etanolsk saltsyre. Smp. 269° etter omkrystallisering fra etanol. cinimide, prepared as described in Example 6, was heated together with 2.17 g of n-butyl toramide and 5 g of sodium carbonate in 25 ems of n-tautonol for 24 hours at reflux. The reaction mixture was evaporated to dryness and the residue taken up in 2-n. hydrochloric acid while cooling. The acidic solution was shaken out once with ether, made alkaline with potash and extracted with ether. From the ether extract tole the hydrochloride of spiro-(1-n-butyl-piperidyl-4)-N-ethyl-succinimide prepared by the addition of ethanolic hydrochloric acid. Temp. 269° after recrystallization from ethanol.

Etter samme fremgangsmåte som angitt i de foregående eksempler, er det fremstillet forbindelser som, sammen med sine egenskaper, er angitt i vedføyde tabell. Following the same procedure as stated in the preceding examples, compounds have been produced which, together with their properties, are indicated in the attached table.

Claims (2)

1. Fremgangsmåte for fremstilling av terapeutisk virksomme, substituerte succinimider med den alminnelige formel I: hvor R[ og R2 kan være like eller forskjel-lige og hver betyr et hydrogenatom eller en lavere alkylgruppe, karakterisert ved at et substituert piperidon-4 med den alminnelige formel II: hvor R/ står for en lavere alkyl- eller en benzylgruppe, omsettes med en forbindelse med den alminnelige formel III: hvor X står for cyangruppen eller en eventuelt funksjonelt omdannet karboksyl-gruppe, i nærvær av en vannavspaltende katalysator til et piperidyliden-4-derivat med den alminnelige formel IV: hvoretter denne ved tilleiring av blåsyre overføres til en forbindelse med den alminnelige formel V: og denne ved hydrolyse, dekarboksylering og forestring med en alkohol overføres til en substituert ravsyre-diester med den alminnelige formel VI: hvoretter den dannede ester omsettes med en nitrogenforbindelse med den alminnelige formel R.,-NH2, hvor R0 har samme betydning som ovenfor og, hvis R/ står for en benzylgruppe, avspaltes denne reduk-tivt og den dannete sekundære aminogrup-pe eventuelt alkyleres.1. Process for the preparation of therapeutically effective, substituted succinimides with the general formula I: where R1 and R2 can be the same or different and each means a hydrogen atom or a lower alkyl group, characterized in that a substituted piperidone-4 with the general formula II: where R/ stands for a lower alkyl or a benzyl group, is reacted with a compound of the general formula III: where X stands for the cyano group or an optionally functionally converted carboxyl group, in the presence of a water-splitting catalyst to a piperidylidene-4 derivative with the general formula IV: after which, by addition of hydrocyanic acid, this is transferred to a compound with the general formula V: and this by hydrolysis, decarboxylation and esterification with an alcohol is transferred to a substituted succinic acid diester with the general formula VI: after which the formed ester is reacted with a nitrogen compound of the general formula R.sub.1-NH2, where R.sub.0 has the same meaning as above and, if R.sub.1 stands for a benzyl group, this is cleaved off reductively and the formed secondary amino group is optionally alkylated. 2. Modifikasjon av fremgangsmåten som er angitt i påstand 1 for fremstilling av et succinimid, som ikke er substituert på nitrogenatomet, karakterisert v e d at forbindelsen med formel V underkastes hydrolyse, dekarboksylering og forestring med en alkohol bare i kort tid, og det dannede substituerte ravsyre-alkyles-ter-amid oppvarmes over smeltepunktet eller kokes i et oppløsningsmiddel.2. Modification of the method stated in claim 1 for the production of a succinimide, which is not substituted on the nitrogen atom, characterized in that the compound of formula V is subjected to hydrolysis, decarboxylation and esterification with an alcohol only for a short time, and the substituted succinic acid formed -alkyl ester amide is heated above the melting point or boiled in a solvent.
NO4050/72A 1971-12-23 1972-11-08 PROCEDURES FOR MANUFACTURING AN EXPANDED EDIBLE PROTEIN PRODUCT. NO135338C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21175871A 1971-12-23 1971-12-23

Publications (2)

Publication Number Publication Date
NO135338B true NO135338B (en) 1976-12-20
NO135338C NO135338C (en) 1977-03-30

Family

ID=22788248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4050/72A NO135338C (en) 1971-12-23 1972-11-08 PROCEDURES FOR MANUFACTURING AN EXPANDED EDIBLE PROTEIN PRODUCT.

Country Status (13)

Country Link
JP (1) JPS4868767A (en)
AU (1) AU476095B2 (en)
CA (1) CA977606A (en)
CH (1) CH562571A5 (en)
DE (1) DE2260828A1 (en)
ES (1) ES409135A1 (en)
FI (1) FI53912C (en)
FR (1) FR2164628B1 (en)
GB (1) GB1389592A (en)
IT (1) IT1049262B (en)
NL (1) NL7216511A (en)
NO (1) NO135338C (en)
SE (1) SE397259B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930045A (en) * 1973-11-20 1975-12-30 Nestle Sa In situ production of meat like flavor in extruded porous food product
DE2837294A1 (en) * 1977-08-29 1979-03-15 Sodes Sa Food prods contg. bran, gluten and flour - prepd. continuously by extruding mixt. with water; used in diet bread, cereals, etc.
DE2845571C2 (en) * 1978-10-19 1985-05-02 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring High fiber extruded snack article
EP0048533A1 (en) * 1980-03-31 1982-03-31 General Foods Corporation Process for preparing meat analogs
JPS6344848A (en) * 1985-11-25 1988-02-25 Ajinomoto Co Inc Preparation of highly expanded food
DE3690664T (en) * 1985-12-27 1988-01-28
US5540932A (en) * 1995-04-13 1996-07-30 Purina Mills, Inc. Extruded animal feed nuggets for ruminants
WO2007001522A2 (en) * 2005-06-17 2007-01-04 Nusci Laboratories Llc Stabilization of oxidized fats
BE1024092B1 (en) * 2014-09-05 2017-11-13 Syral Belgium Nv A PROTEINY MEAT REPLACEMENT WITH AN IMPROVED STRUCTURE AND EXTENDED SHELF LIFE.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3623885A (en) * 1968-12-13 1971-11-30 Archer Daniels Midland Co Extrusion of proteinaceous materials

Also Published As

Publication number Publication date
FI53912C (en) 1978-09-11
FI53912B (en) 1978-05-31
FR2164628B1 (en) 1979-04-27
SE397259B (en) 1977-10-31
IT1049262B (en) 1981-01-20
NO135338C (en) 1977-03-30
AU4881772A (en) 1974-05-16
AU476095B2 (en) 1976-09-09
ES409135A1 (en) 1976-11-16
CH562571A5 (en) 1975-06-13
CA977606A (en) 1975-11-11
GB1389592A (en) 1975-04-03
DE2260828A1 (en) 1973-06-28
FR2164628A1 (en) 1973-08-03
NL7216511A (en) 1973-06-26
JPS4868767A (en) 1973-09-19

Similar Documents

Publication Publication Date Title
SU651695A3 (en) Method of obtaining etherified oxybenzodigeterocycles, or their salts, or optically active antipodes
NO120938B (en)
NO116055B (en)
NO130878B (en)
US3106578A (en) Nu-phenethyl-2-phenylcyclopropylamine derivatives
NO154554B (en) PROCEDURE FOR THE MANUFACTURING OF MINERAL BUILDING FIBERS.
NO135338B (en)
DE3300774A1 (en) NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF
NO166164B (en) EQUIPMENT FOR AA ESTABLISH ELECTRICAL CONNECTION WITH A SINGLE SKIN ELECTRODE.
IE42119B1 (en) Aralkylamine derivatives
CRONYN AZABICYCLOALKANES. 2-AZABICYCLO [3· 3· 1] NONANE1, 2
Mandell et al. The Total Syntheses of d, l-Matrine and d, l-Leontine1
US4010202A (en) 5,6-Dihydroxy aminotetralol compounds
US3056796A (en) 2.8-diazaspiro(4.5)decane-1.3 diones
US2500444A (en) Uramidohomomeroquinene
NO141208B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2- (PHENOXYALKYLTIO) IMIDAZOLE COMPOUNDS
CH301669A (en) Process for the preparation of a morphine derivative.
US2266754A (en) Synthesis of vitamin
SU586835A3 (en) Method of preparing aminopropanol derivatives or their salts,racemates or optically active antipodes
DE2556143A1 (en) 9-AMINOALKYL-9,10-DIHYDRO-9,10-METHANOANTHRACENE
NO143785B (en) PROCEDURE FOR HEAT EXTRACTION OF ALUMINUM ALLOYS WITH HIGH STRENGTH
CH460773A (en) Process for the preparation of substituted 3- (3-hydroxyphenyl) -1-phenacyl-piperidines
US3198800A (en) 2, 8-(para-f-4-oxo-butyl)-diazaspiro[4, 5]-decane-1, 3-diones
US3127405A (en) I-phenylalkyl
DE1211646B (en) Process for the preparation of spirosuccinimides and their salts